Rory B. Riggs - Mar 16, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Mar 16, 2022
Transactions value $
-$13,623,979
Form type
4
Date filed
3/18/2022, 08:12 PM
Previous filing
Jan 4, 2022
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale -$1.21M -20.7K -9.13% $58.72 206K Mar 16, 2022 Held by New Ventures I, LLC F1, F2
transaction ITCI Common Stock Sale -$2.61M -43.8K -21.29% $59.53 162K Mar 16, 2022 Held by New Ventures I, LLC F2, F3
transaction ITCI Common Stock Sale -$1.6M -26.6K -16.4% $59.99 136K Mar 17, 2022 Held by New Ventures I, LLC F2, F4
transaction ITCI Common Stock Sale -$6.94M -115K -84.78% $60.41 20.6K Mar 17, 2022 Held by New Ventures I, LLC F2, F5
transaction ITCI Common Stock Sale -$297K -4.9K -23.75% $60.63 15.7K Mar 18, 2022 Held by New Ventures I, LLC F2, F6
transaction ITCI Common Stock Sale -$965K -15.7K -100% $61.35 0 Mar 18, 2022 Held by New Ventures I, LLC F2, F7
holding ITCI Common Stock 76.8K Mar 16, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $60.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.21 to $60.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.